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Abstract
Background: With the growing prevalence of obesity and metabolic syndrome, reliable quantitative
imaging methods for adipose tissue are required. Monogenic forms of the metabolic syndrome include
Dunnigan-variety familial partial lipodystrophy subtypes 2 and 3 (FPLD2 and FPLD3), which are
characterized by the loss of subcutaneous fat in the extremities. Through magnetic resonance imaging
(MRI) of FPLD patients, we have developed a method of quantifying the core FPLD anthropometric
phenotype, namely adipose tissue in the mid-calf and mid-thigh regions.
Methods: Four female subjects, including an FPLD2 subject (LMNA R482Q), an FPLD3 subject (PPARG
F388L), and two control subjects were selected for MRI and analysis. MRI scans of subjects were
performed on a 1.5T GE MR Medical system, with 17 transaxial slices comprising a 51 mm section obtained
in both the mid-calf and mid-thigh regions. Using ImageJ 1.34 n software, analysis of raw MR images
involved the creation of a connectedness map of the subcutaneous adipose tissue contours within the
lower limb segment from a user-defined seed point. Quantification of the adipose tissue was then obtained
after thresholding the connected map and counting the voxels (volumetric pixels) present within the
specified region.
Results: MR images revealed significant differences in the amounts of subcutaneous adipose tissue in
lower limb segments of FPLD3 and FPLD2 subjects: respectively, mid-calf, 15.5% and 0%, and mid-thigh,
25.0% and 13.3%. In comparison, old and young healthy controls had values, respectively, of mid-calf, 32.5%
and 26.2%, and mid-thigh, 52.2% and 36.1%. The FPLD2 patient had significantly reduced subcutaneous
adipose tissue compared to FPLD3 patient.
Conclusion: Thus, semi-automated quantification of adipose tissue of the lower extremity can detect
differences between individuals of various lipodystrophy genotypes and represents a potentially useful tool
for extended quantitative phenotypic analysis of other genetic metabolic disorders.
Published: 31 August 2006
BMC Medical Imaging 2006, 6:11 doi:10.1186/1471-2342-6-11
Received: 19 June 2006
Accepted: 31 August 2006
This article is available from: http://www.biomedcentral.com/1471-2342/6/11
© 2006 Al-Attar et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
Page 2 of 8
(page number not for citation purposes)
Background
The metabolic syndrome (MetS) related to a pattern of
central or abdominal obesity is a major health concern in
the westernized world. One approach to begin to under-
stand a common complex trait such as MetS is to closely
study individuals who have a rare monogenic analogue of
the condition. In the case of MetS, the familial partial
lipodystrophy syndromes represent an extreme mono-
genic model system that demonstrates the salient clinical
(increased blood pressure and increased abdominal fat)
and biochemical manifestations (increased plasma glu-
cose and triglyceride concentrations and decreased
plasma HDL cholesterol concentration).
The two molecular forms of autosomal dominant Dunni-
gan-type familial partial lipodystrophy (FPLD) result
from mutations either in LMNA encoding nuclear lamin
A/C (FPLD2; MIM 151660) or in PPARG encoding perox-
isome proliferator-activated receptor-γ (FPLD3; MIM
604367) [1-3]. One in 100,000 individuals has FPLD in
North America. Patients with either form of this rare dis-
order show loss of subcutaneous fat, especially from
extremities, together with predisposition to insulin-resist-
ant diabetes, dyslipidemia and hypertension [1-3].
Despite the similar clinical course, there are subtle clinical
phenotypic differences between FPLD2 and FPLD3 [1-3].
For instance, compared to FPLD2 subjects, FPLD3 sub-
jects appear to have less severe adipose involvement on
physical examination, together with more severe clinical
and biochemical manifestations of insulin resistance, and
more variable response to treatment with thiazolidinedi-
one drugs [2,3].
To date, thorough semi-quantitative descriptions of the
localization and extent of fat loss from affected tissues
have taken advantage of both clinical assessment and,
more recently, non-invasive imaging methods, such as
magnetic resonance imaging (MRI) [4-6]. While the
descriptions of MR images in FPLD patients have been
extensive, thorough and detailed, they have not yet been
quantitative [4-6]. Because quantitation of fat mass on
MRI could: 1) enhance the description of these rare disor-
ders; 2) allow for statistical comparisons; and 3) yield new
quantitative traits to follow serially, it is important to
develop robust and replicable tools and methods to quan-
tify subcutaneous fat [7,8]. We now report a method to
quantify lower extremity fat depots in patients with
FPLD2 and FPLD3 from serial MR images that utilized an
almost completely automated strategy. Using the method
developed, the study further reports on quantitative differ-
ences between lower extremity adipose tissue distribution
in the case of two FPLD patients along with comparisons
to matched controls.
Methods
Study subjects
All study subjects were female. The study sample included
an FPLD2 subject (designated GL0096) and an FPLD3
subject (designated GL0658), a young control subject
(designated GL2784) whose body mass index (BMI) was
matched to the FPLD2 subject and an older control sub-
ject (designated GL2990) whose age was matched with
both FPLD subjects and whose BMI was matched to the
FPLD3 subject (Table 1). All subjects provided informed
consent to participate and human ethics approval was
obtained from the University of Western Ontario Institu-
tional Review Board (protocol #11244).
Clinical and biochemical assessment
All subjects provided a medical history and were subjected
to a complete physical examination. Bioimpedance anal-
ysis (BIA) measurements were also gathered using the
Tanita BC-418 Segmental Body Composition Analyzer
(Tanita, Arlington Heights, IL) providing estimates of per-
cent fat for the total body and lower right and left extrem-
ities. The average of three measurements was reported for
each BIA value.
Magnetic resonance imaging and image analysis
MRI scans were obtained at the London Health Sciences
Centre, University Campus, London, Ontario. Scanning
was performed on a 1.5T GE MR Medical system (Model:
Signa Excite) using an 8-channel receive-only torso array
coil. Images of the various sections were acquired using a
T1-weighted Spin Echo pulse sequence with the following
parameters: FOV of 40 cm for mid-calves and 48 cm for
mid-thighs, TR/TE 400/10 ms, bandwidth +/-15.63 kHz, 2
NEX (number of signal averages), and an acquisition
matrix of 256 × 256.
Mid-calf and mid-thigh sections were positioned based on
reference anatomical features. The mid-point of the tibia
was selected for "mid-calf" measurements and the mid-
point of the femur was selected for "mid-thigh" measure-
ments (Figure 1). For both the mid-calf and mid-thigh
regions we acquired image stacks comprised of 17 transax-
ial slice images of 3 mm thickness each, together compris-
ing a total superior/inferior coverage of 51 mm. The MRI
provided a bright, high-threshold adipose tissue signal in
raw image data, relative to other tissues and background.
Other tissues, such as muscle and connective tissue,
appeared as dark regions with low threshold values in MR
images (Figure 2). The whole body scans (Figure 1) are a
composite of four mid-slice coronal stack images acquired
at four stations (head/neck, thoracic/abdominal, pelvic/
thigh, lower leg).BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
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Fat quantification method from MRI
Analysis of the MRI stack images and measurements of
subcutaneous adipose tissue was done by a single
observer using analysis protocols developed in our labo-
ratories (Figure 3). For each MRI data set acquired, the
subcutaneous adipose tissue volume was quantified using
ImageJ version 1.34 n image analysis software [9], specif-
ically utilizing the Connected Threshold Grower and
Voxel Counter tools. Subcutaneous adipose tissue was
defined as the adipose tissue that circulated the circumfer-
ence of the lower limb, adjacent to the skin, as well as any
connected adipose tissue that was infiltrated into the mus-
cle.
Prior to image analysis and fat quantification, all raw
images underwent a preprocessing stage using the auto-
brightness tool in order to minimize background noise
and improve the quality of the images as much as possi-
ble. Images were further standardized with a distance in
pixels set at 1.00 pixel/mm and the image dynamic was
reduced to an 8-bit type to match the requirements of the
used software. Starting from a user-defined seed point
within the subcutaneous adipose tissue in the image, the
method utilized the Connected Threshold Grower tool to
create a connectedness map of the volumetric contours of
subcutaneous adipose tissue within the image stack. This
map represented the strength of connectivity between the
seed point in the subcutaneous region and every voxel
(volumetric pixel) in the image stack. Total tissue and adi-
pose tissue threshold value ranges were obtained by man-
ually sampling the signal intensity in each image stack.
Using this threshold selection mechanism, the connected-
ness map of subcutaneous adipose tissue was then thresh-
olded to segment the volume to be analyzed. Finally, the
contours of segmented subcutaneous adipose tissue were
quantitated using the Voxel Counter tool, which pro-
duced the final output voxel count within the volumetric
region.
Percent adipose tissue was calculated by dividing the total
voxels determined for fat intensity signals connected to
the subcutaneous adipose seed point by the total voxels
for the slice (Figure 3). After the percent adipose tissue was
calculated for each slice, the average of 17 slices was
reported as the average percent adipose tissue/slice. The
percent volume of fat for each region was also obtained by
adding the fat intensity voxels for all 17 slices (total fat
volume) and then dividing them by the sum of the total
voxel areas (total region volume).
Statistical analysis
Subcutaneous adipose measurements from MRI were sta-
tistically analyzed using SAS version 8.2 (SAS Institute,
Cary, NC). The Pearson correlation coefficient was used to
test variation among duplicate blinded subcutaneous adi-
pose tissue measurements made by the same observer on
different days in the mid-calf and mid-thigh (intra-
observer variability) and also to test inter-observer varia-
Table 1: Characteristics of FPLD patients compared to controls
GL2784 GL2990 GL0658 GL0096
Diagnosis Control Control FPLD3 FPLD2
Mutation Wild-type Wild-type PPARG F388L LMNA R482Q
Age (years) 24 50 49 63
Sex Female Female Female Female
Height (m) 1.63 1.60 1.52 1.53
Weight (kg) 61.7 89.1 80.2 58.1
Body mass index (kg/m2) 23.5 34.8 33.4 24.8
Waist circumference (cm) 78.8 103.6 105.7 88.3
Waist-to-hip circumference ratio 0.88 0.86 0.88 0.92
Blood pressure (mmHg) 113/63 154/89 138/88 (treated) 131/76 (treated)
BIA measures (PBF, %)
total body 28.0 ± 0.2 47.5 ± 0.2 31.8 ± 0.2 29.7 ± 0.1
right leg 31.4 ± 0.1 49.5 ± 0.1 44.0 ± 0.2 36.8 ± 0.1
left leg 31.3 ± 0.1 49.2 ± 0.1 47.9 ± 0.5 37.7 ± 0.1
Mean sc+inf volume/slice (%)
mid-calf 26.3 ± 1.1 34.8 ± 1.5 19.2 ± 1.7 N/A
mid-thigh 44.3 ± 2.1 56.1 ± 1.5 34.4 ± 2.5 24.3 ± 3.7
Overall sc+inf volume (%)
mid-calf 26.2 34.7 19.2 N/A
mid-thigh 44.5 56.1 34.5 24.5
Abbreviations: FPLD, familial partial lipodystrophy; BIA, bioimpedance analysis; PBF, percent body fat; MRI, magnetic resonance imaging; sc+inf fat, 
subcutaneous plus infiltrated fat; N/A, could not be assessed (no visible subcutaneous fat)BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
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tion for the same samples, analyzed by a different
observer. The t-test for unequal variances was used to test
for differences in mean percent subcutaneous adipose
between FPLD subjects and normal controls. A nominal
P-value < 0.05 was chosen as the threshold for significance
for all statistical comparisons.
Results
Baseline clinical and anthropometric features of study 
subjects
The clinical and anthropometric features of the study sub-
jects are displayed in Table 1. Compared to control subject
GL2784 (female, aged 24), control subject GL2990
(female, aged 50), who met blood pressure and waist cir-
cumference cut points of the National Cholesterol Educa-
tion Program Adult Treatment Program III (NCEP ATP III)
criteria for diagnosis of the metabolic syndrome (MetS),
had higher BMI, waist circumference (but not ratio of
waist-to-hip circumference), and percent body fat (PBF)
for the total body and lower extremities, as measured by
segmental body composition MRI analysis. Compared to
controls, FPLD3 subject GL0658, who also met the blood
pressure and waist circumference cut points of the NCEP
ATP III criteria for MetS, had similar ratio of waist-to-hip
circumference, similar BMI and percent lower extremity
fat to age-matched control GL2990, but lower total body
PBF compared to the same age-matched control (Table 1).
Compared to controls, FPLD2 subject GL0096, who also
met blood pressure and waist circumference criteria of the
NCEP ATP III definition for MetS, had increased ratio of
Full body coronal magnetic resonance image of the subjects in the study and the assigned survey fields in the mid-calf and mid- thigh Figure 1
Full body coronal magnetic resonance image of the subjects in the study and the assigned survey fields in the 
mid-calf and mid-thigh. On these survey images the horizontal bars indicate the location of the mid-calf and mid-thigh sec-
tions, positioned based on reference anatomical features. The mid-point of the tibia was selected for "mid-calf" measurements 
and the mid-point of the femur was selected for "mid-thigh" measurements. Subjects from left to right are normal controls, 
GL2784 and GL2990, followed by the FPLD3 patient (GL0658) and FPLD2 patient (GL0096).BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
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waist-to-hip circumference (android pattern). BMI and
PBF for the total body and lower extremities for FPLD2
subject GL0096 was similar to young control GL2784 and
significantly less than older control GL2990 (Table 1).
Qualitative differences on survey MRIs
Qualitative coronal regional fat distribution profile differ-
ences between affected and normal controls are shown in
Figure 1. The main visible differences included: 1) greater
subcutaneous fat depots, especially around the hips and
thighs, for the two control subjects compared with the
FPLD3 and FPLD2 subjects; and 2) attenuation of subcu-
taneous fat stores at a lower point on the thigh of the
FPLD3 subject compared to the FPLD2 subject.
Intra- and inter-observer correlations for quantitative MRI 
analysis
Intra-observer correlation was determined by comparing
two replicates of percent subcutaneous fat for both the
mid-calf and mid-thigh derived from subjects GL2784,
GL2990, GL0658 and GL0096. Each replicate involved
analysis of 17 transaxial images for both the right and left
sides. Intra-observer correlation coefficients based on at
least 68 sections each were, on average, 0.996 for the mid-
calf and 0.998 for the mid-thigh. Inter-observer correla-
tion was determined by comparing percent subcutaneous
fat for both the mid-calf and mid-thigh derived from sub-
jects GL2784, GL2990, GL0658 and GL0096, as measured
by two independent observers. Each determination
involved analysis of 17 transaxial images for both the
right and left sides. The overall inter-observer correlation
coefficients were, on average, 0.988 for the mid-calf and
0.991 for the mid-thigh.
Quantification of subcutaneous fat from MRI
Quantification of the percent subcutaneous adipose tissue
present in the mid-calf and mid-thigh regions showed that
the control subjects had values ranging from 26-56%,
with mid-thigh values always greater than mid-calf values.
The older control subject GL2990 (BMI 34.8) had percent
subcutaneous adipose tissue values that were ~1.3-fold
greater than the younger, normal weight control subject
GL2784 P < 0.0001). The FPLD3 subject GL0658 had sig-
nificantly lower percent adipose tissue values for both the
mid-calf and mid-thigh regions in comparison to both
control subjects (P < 0.0001 for both). The most signifi-
cant attenuation in subcutaneous adipose tissue was
observed for the FPLD2 subject, where no subcutaneous
connectedness map of fat was attainable for the minute
remnants of adipose tissue present in the perimeter of
mid-calf region, and thus quantification using the auto-
mated Connected Threshold Grower tool was impossible.
The percent subcutaneous adipose tissue in the mid-thigh
of FPLD2 subject GL0096 was also significantly lower
than that observed for FPLD3 subject GL0658 (24.3 ±
3.7% vs 34.4 ± 2.5%, P < 0.0001).
Mean and overall percent adipose tissue values are
reported (Table 1), representing averaged values of indi-
vidual slices composing each respective image stack and
Transaxial magnetic resonance images at the levels of mid-calf (top slice images) and mid-thigh (bottom slice images) of the sub- jects in the study Figure 2
Transaxial magnetic resonance images at the levels of mid-calf (top slice images) and mid-thigh (bottom slice 
images) of the subjects in the study. Bright/white signals in these images are highlighting adipose tissue within these ana-
tomical sections. Dark signals represent either muscle tissue within sections or the background of the images. Subject GL2784 
is a healthy 24 year old woman whose MRI showed no infiltrated fat into calf muscle, and only small amount of infiltration in the 
thigh. Subject GL2990 is a normal 50 year old woman who had somewhat increased subcutaneous (sc) fat in the calves and 
mid-thigh with slightly more infiltration of fat into the muscle compared to the images of subject GL2784. Subject GL0658 is a 
49 year old FPLD3 patient (heterozygous for mutation PPARG F388L) whose scans show moderate loss of sc fat in both the 
calves and mid thigh and moderate levels of fat infiltration. Subject GL0096 is a 63 year old FPLD2 patient (heterozygous for 
mutation LMNA R482Q) whose scan shows total sc fat loss in the calves, major sc fat loss in the mid-thigh and marbled appear-
ance of muscle tissue due to severe amounts of fat being stored within the muscle.BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
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values of total volume subcutaneous adipose tissue
respectively. Each of these values is also an average of two
replicate data sets from two independent analyses. The
correlation (r) between mean subcutaneous fat areas and
overall fat volume was 0.99998.
Discussion
Using a strategy to quantify subcutaneous fat in the lower
extremity that was based on connectivity analysis, we
found significant differences between subcutaneous adi-
pose tissue in the mid-calf and mid-thigh sections of FPLD
patients compared to normal controls. We found signifi-
cantly reduced lower extremity subcutaneous adipose tis-
sue in a subject with FPLD2 than in a subject with FPLD3.
Specifically, no subcutaneous adipose tissue could be
quantified in the calf of the FPLD2 patient compared to
19.2 ± 1.7% subcutaneous adipose tissue in FPLD3 (P <
0.0001). Similarly, the percent subcutaneous adipose tis-
sue in the thigh was 24.3 ± 3.7% and 34.4 ± 2.5% (P <
0.0001), for the FPLD2 and FPLD3 patients respectively.
Current clinical assessment of adipose tissue distribution
in common obesity and metabolic syndrome and subjects
with FPLD2 and FPLD3 is still in its infancy. Also, BIA
failed to capture differences in percent fat in lower extrem-
ities in FPLD2 vs FPLD3 perhaps because so much fat was
infiltrated into muscle in FPLD2. In contrast, MRI adipose
connectedness maps and semi-automated subcutaneous
adipose tissue quantification with very high resolution
and reproducibility, captured traits that could be com-
pared statistically, confirming the subtle clinical differ-
ences [3,10].
This semi-automated method involved a Connected
Threshold Grower tool which specified inclusion of only
adipose tissue connected to the initial subcutaneous seed
point. Based on this pilot study of FPLD patients, we
observed very high intra- and inter-observer correlation
values: r > 0.99 and >0.98, respectively. In addition to its
reproducibility, the described method yields results
quickly and accurately, with minimal user intervention.
The method was limited by including only connected
infiltrated adipose tissue. However, given the imprecise
definition of subcutaneous adipose tissue in extremities,
we elected to include the connected infiltrated adipose tis-
sue in our calculations, again since this would require no
user judgment and/or intervention, thus reducing another
potential source of analytic variation. An additional limi-
tation inherent in the ImageJ software, which does not
affect reproducibility but affects image dynamic, is that of
the 16-bit to 8-bit change to the image stacks prior to anal-
ysis. This reduction in image dynamic, which reduces res-
olution, is a common setback in medical image
processing where similar general-purpose software librar-
ies are used. Future development of the software to utilize
original raw images would be advantageous in maintain-
ing image integrity and reflecting more accurate analysis
data acquired from quantification.
Evaluating FPLD patients theoretically allowed for assess-
ment of the lower limits of resolution of the method;
however, the method appeared insensitive for calf adipose
measurements in FPLD2, since there was no subcutane-
ous fat according to the definition specified in the quanti-
fication methodology. Future application of this
quantification method may include quantification of
both thigh and calf depots for "garden variety" obesity,
metabolic syndrome or diabetes. This approach might
also be applicable to quantify metabolically important
substrata of fat [11].
We recognize that this study was limited due to the small
subject numbers from whom subcutaneous adipose tissue
Quantification of percent adipose tissue Figure 3
Quantification of percent adipose tissue. For each of 
the 17 transaxial slices in a given anatomical section, both the 
total volume and the total subcutaneous (sc) and connected 
infiltrated (inf) fat volumes were selected using the Con-
nected Threshold Grower tool. Their corresponding vol-
umes were determined using the Voxel Counter tool. The 
percent adipose tissue was calculated for each slice by divid-
ing the total voxels determined for the sc + inf fat by the 
total voxels for the slice. The percent adipose tissue was 
determined for each slice alone and also for the overall sec-
tion, combining the results from all 17 slices.BMC Medical Imaging 2006, 6:11 http://www.biomedcentral.com/1471-2342/6/11
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values were extracted. Acquisition of such values from a
larger number of patients with both FPLD subtypes would
verify the likely results observed here. Furthermore, con-
trols were not ideally matched for age and BMI: while the
FPLD2 patient had a similar BMI as the young control
individual, unmeasured and uncontrolled factors related
to age might have further contributed to variation in sub-
cutaneous adipose tissue. Expanding the sample size in
future studies would clearly be helpful in this regard.
The whole body scans suggested that this method can be
adapted for other fat depots or bodily organs. However,
widespread application would depend on development of
standards with respect to regions surveyed, anatomical
landmarks, number of measurements, etc – similar to the
consensus standards agreed upon for carotid intima-
media thickness measurements using ultrasound. Also,
intramuscular fat is distributed either in intra- or inter-
myocellular depots; which could be more specifically
evaluated using proton magnetic resonance spectroscopy
(MRS) and/or fat selective MRI [12-14]. Such regional dis-
tribution could be an additional MRI analyte that could
be considered together with other intermediate traits in
subjects with FPLD or even common metabolic syn-
drome. Furthermore, it is possible to obtain carbon-13
nuclear magnetic resonance (NMR) spectra of human
muscle glycogen in vivo in diabetic patients [15], which
has helped understand the pathogenesis of insulin resist-
ance, metabolic syndrome and type 2 diabetes. Quantifi-
cation of fat depots using MRI and appropriate image
analysis software could provide complementary analytes
for research and perhaps eventually for the diagnosis and
monitoring of interventions.
Conclusion
In summary, we report the use of MRI and image analysis
software employing Connected Threshold Grower and
Voxel Counter tools to help quantify lower extremity sub-
cutaneous fat depots in patients with two molecular forms
of partial lipodystrophy. We also showed that the meas-
urements showed high intra- and inter-observer correla-
tion in a small sample. Finally, the measurements could
be compared statistically and thus confirmed the clinical
impression that FPLD2 and FPLD3 differ with respect to
the extent of subcutaneous fat loss; specifically, subcuta-
neous fat loss in the FPLD2 subject is greater than in the
FPLD3 individual. Increasing the sample size of FPLD
subjects in future studies will validate this interpretation.
These tools can be applied immediately and might be use-
ful in quantitative phenotype analysis of other forms of
lipodystrophy and in less extreme disorders of fat redistri-
bution or repartitioning, such as "garden variety" obesity,
insulin resistance, or type 2 diabetes.
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